Utility of convalescent plasma for COVID-19 treatment
The novel coronavirus identified and designated as SARS-CoV-2 has brought unprecedented suffering to people across the globe. There is yet neither an effective therapeutic substance nor a vaccine to treat the disease. Intensive research is being carried out globally to combat the menace. The road to...
Main Author: | Prasanta Kumar Ghosh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | MGM Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.mgmjms.com/article.asp?issn=2347-7946;year=2020;volume=7;issue=4;spage=166;epage=175;aulast=Ghosh |
Similar Items
-
Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
by: Douglas Tremblay, et al.
Published: (2020-11-01) -
The Three Pillars of COVID-19 Convalescent Plasma Therapy
by: Massimo Franchini, et al.
Published: (2021-04-01) -
Convalescent plasma therapy as a conventional trick for treating COVID-19: a systematic review and meta-analysis study
by: M. Keikha, et al.
Published: (2021-07-01) -
Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients – propensity-score matched case-control study
by: Adam Tworek, et al.
Published: (2021-04-01) -
The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
by: Livius Tirnea, et al.
Published: (2021-03-01)